Home > Annual Financials > ALBERT DAVID

ALBERT DAVID Financial Statement Analysis
[BOM: 524075|NSE : ALBERTDAVD]

The Revenues of ALBERT DAVID have increased by 8.95% YoY .
The Earnings Per Share (EPS) of ALBERT DAVID has increased by 2.59 % YoY.
REVENUES
OPERATING MARGIN
PROFIT AFTER TAX
EPS
ROCE

ALBERT DAVID Last 5 Annual Financial Results
[BOM: 524075|NSE : ALBERTDAVD]

StandaloneMar2023
Mar2022
Mar2021
Mar2020
Mar2019
Revenues ₹342 Cr₹314 Cr₹247 Cr₹321 Cr₹317 Cr
Expenses ₹297 Cr₹273 Cr₹228 Cr₹290 Cr₹288 Cr
Operating Profit (Excl OI) ₹44 Cr₹41 Cr₹19 Cr₹31 Cr₹29 Cr
Other Income ₹15 Cr₹16 Cr₹17 Cr₹7.11 Cr₹21 Cr
Interest ₹0.58 Cr₹0.67 Cr₹0.78 Cr₹0.99 Cr₹0.86 Cr
Depreciation ₹8.55 Cr₹8.81 Cr₹8.23 Cr₹7.68 Cr₹7.02 Cr
Profit Before Tax ₹51 Cr₹47 Cr₹27 Cr₹29 Cr₹43 Cr
Profit After Tax ₹36 Cr₹35 Cr₹22 Cr₹19 Cr₹27 Cr
Consolidated Net Profit ₹36 Cr₹35 Cr₹22 Cr₹19 Cr₹27 Cr
Earnings Per Share (Rs)₹63.38₹61.78₹38.80₹33.59₹46.68
PAT Margin (%)10.0310.668.505.687.99
ROE(%)12.2413.469.488.8513.44
ROCE(%)17.1018.1011.9913.7420.60
Total Debt/Equity(x)0.020.020.010.010.00

Key Financials

Market Cap : ₹ 679.1 Cr
Revenue (TTM) : ₹ 354.8 Cr
Net Profit(TTM) : ₹ 66.2 Cr
EPS (TTM) : ₹ 116.2
P/E (TTM) : 10.3

Industry Peers & Returns1W1M1Y
ALBERT DAVID 4.4% 10.5% 100.6%
SUN PHARMACEUTICAL INDUSTRIES -0.1% -2.8% 50.3%
CIPLA 4.5% -3.1% 52.8%
DR REDDYS LABORATORIES 4.6% 1.4% 22.2%
ZYDUS LIFESCIENCES 3.1% -4.1% 80.4%
DIVIS LABORATORIES 4.7% 10.8% 18.1%
MANKIND PHARMA 2.7% 12.4% NA
TORRENT PHARMACEUTICALS 6.1% 5.3% 66.2%
LUPIN 3.1% -1.1% 127.4%


ALBERT DAVID Revenues
[BOM: 524075|NSE : ALBERTDAVD]

Y-o-Y

8.95 %

5 Yr CAGR

1.87 %

Years Revenues % Change
Mar2023 ₹342 Cr
8.95
Mar2022 ₹314 Cr
26.70
Mar2021 ₹247 Cr
-22.86
Mar2020 ₹321 Cr
1.13
Mar2019 ₹317 Cr -


ALBERT DAVID Operating Profit
[BOM: 524075|NSE : ALBERTDAVD]

Y-o-Y

8.64 %

5 Yr CAGR

11.05 %

Years Operating Profit % Change
Mar2023 ₹44 Cr
8.64
Mar2022 ₹41 Cr
112.32
Mar2021 ₹19 Cr
-36.80
Mar2020 ₹31 Cr
4.30
Mar2019 ₹29 Cr -

Operating Margins
Y-o-Y

-0.31 %

5 Yr CAGR

9.01 %

Years Operating Margin% % Change
Mar2023 13.02%
-0.31
Mar2022 13.06%
67.65
Mar2021 7.79%
-18.09
Mar2020 9.51%
3.15
Mar2019 9.22% -

ALBERT DAVID Profit After Tax
[BOM: 524075|NSE : ALBERTDAVD]

Y-o-Y

2.60 %

5 Yr CAGR

7.95 %

Years Profit After Tax % Change
Mar2023 ₹36 Cr
2.60
Mar2022 ₹35 Cr
59.23
Mar2021 ₹22 Cr
15.51
Mar2020 ₹19 Cr
-28.04
Mar2019 ₹27 Cr -

PAT Margins
Y-o-Y

-5.91 %

5 Yr CAGR

5.85 %

Years PAT Margin(%) % Change
Mar2023 10.03 %
-5.91
Mar2022 10.66 %
25.41
Mar2021 8.5 %
49.65
Mar2020 5.68 %
-28.91
Mar2019 7.99 % -

ALBERT DAVID Earnings Per Share (EPS)
[BOM: 524075|NSE : ALBERTDAVD]

Y-o-Y

2.59 %

5 Yr CAGR

7.95 %

Years EPS % Change
Mar2023 ₹63
2.59
Mar2022 ₹62
59.23
Mar2021 ₹39
15.51
Mar2020 ₹34
-28.04
Mar2019 ₹47 -

ALBERT DAVID Return on Capital Employed (ROCE)
[BOM: 524075|NSE : ALBERTDAVD]

Y-o-Y

-5.52 %

5 Yr CAGR

-4.55 %

Years ROCE % Change
Mar2023 17.1%
-5.52
Mar2022 18.1%
50.96
Mar2021 11.99%
-12.74
Mar2020 13.74%
-33.30
Mar2019 20.6% -

ALBERT DAVID Share Price vs Sensex

Current Share Price : ₹1,191.5
Current MarketCap: ₹ 679.1 Cr
Updated EOD on :Apr 26,2024

Share Price Returns(%) 1 Week 1 Month 1 Year
ALBERT DAVID

4.4%

10.5%

100.6%

SENSEX

0.9%

1.5%

23.6%

ALBERT DAVID related INDICES

No BSE index found!
No NSE index found

You may also like the below Video Courses


FAQ about ALBERT DAVID Financials


How the annual revenues of ALBERT DAVID have changed ?

The Revenues of ALBERT DAVID have increased by 8.95% YoY .

How the Earnings per Share (EPS) of ALBERT DAVID have changed?

The Earnings Per Share (EPS) of ALBERT DAVID has increased by 2.59 % YoY .